Stock listing

43Z Stock Price, News, Filings & Events — Schrodinger, Inc.

Selected listing: 43Z · DUS · EUR · DE

This page tracks Schrodinger, Inc.'s 43Z:DUS listing on DUS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 43Z:DUS. 43Z:DUS is the stock-level entry point for investors researching Schrodinger, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Schrodinger, Inc. (ticker: SDGR) is a public company based in the United States with a market capitalization of approximately $1.14 billion. The company focuses on advancing drug discovery and materials science through its proprietary computational platform. Schrodinger aims to enhance the efficiency of research and development processes in various industries.

43Z:DUSEURDEUpdated September 11, 2026
Schrodinger, Inc. logo
Ticker
43Z:DUS
Asset type
Stock
Market cap
$1.42B
Sector
Technology Services
Industry
Packaged Software
Exchange
DUS
Currency
EUR

Schrodinger, Inc. 43Z:DUS stock context

This page tracks Schrodinger, Inc.'s 43Z:DUS listing on DUS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 43Z:DUS. 43Z:DUS is the stock-level entry point for investors researching Schrodinger, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Schrodinger, Inc. (ticker: SDGR) is a public company based in the United States with a market capitalization of approximately $1.14 billion. The company focuses on advancing drug discovery and materials science through its proprietary computational platform. Schrodinger aims to enhance the efficiency of research and development processes in various industries.

Latest news from Schrodinger, Inc.

All Schrodinger, Inc. news →

Schrodinger, Inc. earnings calls

Research Schrodinger, Inc.

Alternate listings